Slide 1: Q4 2024 Supplemental Financial Information
February 25, 2025 Q4 2024 Supplemental Financial Information
Slide 2: Use of Non-GAAP Financial Measures
Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three and twelve months ended December 31, 2024, and December 31, 2023, and for the fiscal year ended December 31, 2022. Management believes that no
Slide 3: Q4 2024 Results
Q4 2024 Results Revenue by region and category Total by Category Q4 2024 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $22.4 million 24.1% 28.0% domestic sales Business-to-business $28.3 million 31.5% 35.4% international sales Direct-to-consumer $15.6 million (21.3)% 19.5% do
Slide 4: Full Year 2024 Results
Full Year 2024 Results Revenue by region and category Total by Category FY 2024 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $83.6 million 26.2% 24.9% domestic sales Business-to-business $117.2 million 31.1% 34.9% international sales Direct-to-consumer $78.0 million (18.8)%
Slide 5: Operating Expense and Net Loss
Operating Expense and Net Loss (in thousands) Three months ended Twelve months ended December 31, December 31, 2024 2023 2024 2023 Operating expense Research and development $ 5,898 $ 6,714 $ 21,610 $ 20,840 Sales and marketing 24,155 25,653 103,069 107,091 General and administrative 17,622 24,773 7
Slide 6: Reconciliation of GAAP to Non-GAAP: Adjusted EBITDA
Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended Twelve months ended December 31, December 31, Non-GAAP EBITDA and Adjusted EBITDA 2024 2023 2024 2023 Net loss (GAAP) $ (9,757) $ (26,555) $ (35,888) $ (102,449) Non-GAAP adjustments: Interest income, net (1,413) (1
Slide 7: Reconciliation of GAAP to Non-GAAP: Adjusted Net Loss
Reconciliation of GAAP to Non-GAAP Adjusted Net Loss (in thousands) Three months ended December 31, Net Loss Diluted EPS Non-GAAP Adjusted Net Loss and Diluted EPS 2024 2023 2024 2023 Financial Results (GAAP) $ (9,757) $ (26,555) $ (0.41) $ (1.14) Non-GAAP adjustments: Amortization of intangibles 1,
Slide 8: Stock-Based Compensation
Stock-Based Compensation (in thousands) Years ended December 31, Stock-based compensation expense by type of award: 2024 2023 2022 Restricted stock units and restricted stock awards $ 6,941 $ 7,037 $ 11,748 Employee stock purchase plan 456 390 535 Total stock-based compensation expense $ 7,397 $ 7,4
Slide 9: Improving lives through respiratory care
Improving lives through respiratory care